Publication | Open Access
IMvigor210: updated analyses of first-line (1L) atezolizumab (atezo) in cisplatin (cis)-ineligible locally advanced/metastatic urothelial carcinoma (mUC)
10
Citations
0
References
2016
Year
UrologyUpdated AnalysesGenitourinary CancerAdvanced/metastatic Urothelial CarcinomaMedicineCancer GenomicsMolecular OncologyCancer TreatmentOncologyRadiation OncologyCancer Research
No additional data available for this publication yet. Check back later!